|
|
OmniComm has numerous clients using our products for late phase studies. From prospective observational studies, to registries, to approved products research, OmniComm has the software, experience and service to deliver successful outcomes for electronic data capture. Recognizing the constraints this phase of research often brings, OmniComm has developed licensing models to meet the needs of the industry, both in terms of duration and price. With the ever-increasing visibility late-phase studies have with regulatory agencies, fast, accurate and access to clean data are critical in today’s environment. Let OmniComm show you how we have helped other clients perform better in late-phase clinical studies. If you would like to learn more, please contact Bev Hudson bhudson@omnicomm.com |